skip to main content

W. Jay Treat, Ph.D.

Chief Manufacturing Officer and Principal Investigator

Dr. Treat is a well-recognized technical and bioprocessing leader with 28+ years of broad industrial experience and demonstrated accomplishments in biologics (recombinant proteins, monoclonal antibodies, viral vaccines and algae), diagnostics and vaccine manufacturing process development, scale-up, characterization, technology transfer, manufacturing, quality assurance and regulatory support. He has been providing scientific excellence and strategic leadership within multifunctional CMC teams on over 250+ large molecules, peptides, MSCs, small molecules and vaccines plus >1,500 diagnostics including IVF. His experience in quality systems and regulatory include 65+ INDs, 2 IDEs, +1,500 510Ks and numerous FDA, EMA, and ISO inspections. Manufacturing experience extends from bench scale bioreactors to 30,000L biologics to +120,000L for algae.

Prior to joining Texas A&M University as Director of the National Center for Therapeutics Manufacturing working closely with BARDA and the CIADM teams, he served as President and Chief Technology Officer at Bone Biologics Corporation, Chief Operating Officer at Avid Bioservices CDMO where he oversaw biologic manufacturing from conception to commercial licensing of the facility, VP of R&D at Irvine Scientific for cell culture media and IVG to various leadership positions including process development, manufacturing and Quality Systems at BioWhittaker and later Cambrex involving cell culture media, LAL, instrumentation, small molecule chemical synthesis, and marketing.  

Dr. Treat received his Bachelor of Science of Microbiology in 1979, his Master of Science of Microbiology in 1982, and his Doctor of Philosophy of Agricultural and Biochemical Engineering in 1988 from Texas A&M University in College Station, Texas.  Dr. Treat is also a graduate of the Center for Creative Leadership in partnership with Cambrex in 1998 and the Executive Development MBA Program through Columbia University at Ardan Hill in 1998.  Dr. Treat was a member of the Texas A&M University Chemical Engineering Scientific Advisory Board from 2000-2014.  He was also a previous member of Emergent BioSolutions and XOMA, LLC External Advisory Boards.

Last edited by: brandon.theis